BVS Earnings
Latest Revenue153.2M
Latest Net Income36.2M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.49 | 153.2M | 36.2M | +3.8% | +345.5% |
| Q1 2026 | $0.05 | 132.1M | 3.9M | +6.6% | +225.0% |
| Q4 2025 | $0.22 | 157.9M | 17.3M | +2.8% | +2,300.0% |
| Q3 2025 | $0.05 | 138.7M | 4.0M | -0.2% | +162.5% |
| Q2 2025 | $0.11 | 147.7M | 9.3M | -2.4% | +127.5% |
| Q1 2025 | -$0.04 | 123.9M | -3322000 | -4.3% | +50.0% |
| Q4 2024 | -$0.01 | 153.6M | -603000 | +13.5% | +90.0% |
| Q3 2024 | -$0.08 | 139.0M | -5848000 | +15.0% | +33.3% |
| Q2 2024 | -$0.40 | 151.2M | -34217000 | — | — |
| Q1 2024 | -$0.08 | 129.5M | -6381000 | — | — |
| Q4 2023 | -$0.10 | 135.4M | -22593000 | — | — |
| Q3 2023 | -$0.12 | 120.8M | -8791000 | — | — |
Bioventus (BVS) — Earnings